Evidence map›Paper›PMID 41613674›Full record

ArticleCureus2025

Intra-abdominal Desmoid Tumors Mimicking Gastrointestinal Stromal Tumor (GIST) Recurrence: A Case Report.

Yoko Senaha, Takeshi Matsubara, Shunsuke Kaji, Hikota Hayashi, Masaaki Hidaka

Abstract readCase Reports
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yoko SenahaDepartment of Digestive and General Surgery, Shimane University, Izumo, JPN.
Takeshi MatsubaraDepartment of Digestive and General Surgery, Shimane University, Izumo, JPN.
Shunsuke KajiDepartment of Digestive and General Surgery, Shimane University, Izumo, JPN.
Hikota HayashiDepartment of Digestive and General Surgery, Shimane University, Izumo, JPN.
Masaaki HidakaDepartment of Digestive and General Surgery, Shimane University, Izumo, JPN.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Desmoid tumors, also known as aggressive fibromatosis, are rare, benign soft tissue neoplasms characterized by local invasiveness and a high recurrence rate. They can mimic malignant tumors, particularly in patients with a history of gastrointestinal stromal tumors (GISTs). We report a case of a 60-year-old male who developed intra-abdominal desmoid tumors five years after undergoing laparoscopy and endoscopy cooperative surgery (LECS) for gastric GIST, followed by adjuvant imatinib therapy. Imaging studies, including contrast-enhanced computed tomography (CT) and positron emission tomography-computed tomography (PET-CT), revealed two mesenteric masses. The larger lesion demonstrated elevated fluorodeoxyglucose (FDG) uptake (SUVmax = 6.7), raising suspicion for recurrent GIST. Surgical resection was performed, and histopathological examination confirmed the diagnosis of desmoid tumors. Immunohistochemical analysis showed positive β-catenin staining, with negative markers for CD34, desmin, and c-kit, distinguishing it from recurrent GIST. This case highlights the diagnostic challenge of differentiating desmoid tumors from GIST recurrence based on imaging alone. Histopathological confirmation remains crucial for accurate diagnosis. Surgical resection is the primary treatment for symptomatic desmoid tumors, but given their high recurrence rate, long-term follow-up and a multidisciplinary approach are essential for optimal management.

Indexed as

desmoid tumorgastrointestinal stromal tumor (gist)histopathological analysisimaging modalitiesintra-abdominal mass

Identifiers

PMID41613674
PMCPMC12848327

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.